EFPIA - NEWSLETTER

EFPIA Newsletter 11 February 2021

19 Conversations | The EFPIA podcast series

By Chris Skedgel (Office of Health Economics)

Today we're asking Chris Skedgel, Director at the Office of Health Economics:

"Can a shared understanding of unmet medical needs support innovation?".

News

09 February 2021 Using the FMD Data Repositories for Shortages Monitoring

Patient health and safety is of the utmost importance to the stakeholders that have put every effort in place to implement...

09 February 2021 EFPIA response to the Cross-border Healthcare Directive

Giving patients access to safe and high-quality healthcare and encouraging cooperation across the European Union

Videos

What do the different types of COVID-19 vaccine approvals mean?

With several COVID-19 vaccines approved across the EU, UK and USA, and more expected soon, Muriel Pasté, Head of Regulatory Intelligence & Strategy, GSK explores the differences between the vaccine approvals terminology and what they mean.

#WeWontRest until we beat cancer

We are committed to working with all stakeholders to achieve tangible progress for today’s and tomorrow’s cancer patients, keeping the EU at the forefront of research and innovation.

Events

23 FEB 2021

Unlocking the Potential of Precision Medicine in Europe Virtual Event

How to improve cancer care through broader access to quality biomarker testing

Learn more →

25 FEB 2021

Blueprint for Action on Diabetes in the European Union by 2030 Virtual Event

MEPs Mobilising for Diabetes Webinar

Learn more →

What we are reading

Myths of Vaccine Manufacturing 02 February 2021 (Science Translational Medicine)

Pharma groups ‘losing time’ with EU export control mechanism 05 February 2021 (Euractiv)

EU industry group warns new export rules threaten COVID-19 vaccine production and supply 08 February 2021 (BioPharma-Reporter.com)

Patents are not an obstacle to ramp up COVID-19 vaccines production, EU says 08 February 2021 (Euractiv)

Happy Anniversary EU FMD 09 February 2021 (Grant Courtney, via LinkedIn)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶